# Edwards Lifesciences acquires JenaValve Technology

Edwards Lifesciences has signed an agreement to acquire JenaValve Technology, a pioneer in transcatheter treatment of aortic regurgitation. JenaValve is a portfolio company of Andera Partners.

- Type: Acquisition
- Announced: 2024-07-24
- Where: United States
- Status: announced
- Products: transcatheter heart valves for aortic regurgitation
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (acquirer)
- [Genesis MedTech](https://endata.com/companies/45413.md) (target)
- [Andera Partners](https://endata.com/companies/52516.md) (investor)
- [JenaValve Technology](https://endata.com/companies/60411.md) (target)
- [JC Medical](https://endata.com/companies/60843.md) (target)

## Sources

- [anderapartners.com](https://www.anderapartners.com/en/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences/), 2024-07-25: "JenaValve Technology has signed an acquisition deal with Edwards Lifesciences."
- [prnewswire.com](https://www.prnewswire.com/news-releases/peijia-medicals-licensing-partner-jenavalve-technology-inc-is-expected-to-be-acquired-by-edwards-lifesciences-302206503.html), 2024-07-25: "Edwards announced that it had entered into an agreement to acquire JenaValve"
- [massdevice.com](https://www.massdevice.com/edwards-acquires-valve-maker-jc-medical/), 2024-08-19: "J-Valve has unique advantages in treating aortic valve regurgitation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.